These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26477317)

  • 1. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
    D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
    Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution.
    Zhao K; Chai X; Johnston K; Clements A; Marmorstein R
    J Biol Chem; 2001 Apr; 276(15):12120-7. PubMed ID: 11152481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer.
    Chen Y; Dey R; Chen L
    Structure; 2010 Feb; 18(2):246-56. PubMed ID: 20159469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.
    Kamada R; Nomura T; Anderson CW; Sakaguchi K
    J Biol Chem; 2011 Jan; 286(1):252-8. PubMed ID: 20978130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sliding of p53 along DNA can be modulated by its oligomeric state and by cross-talks between its constituent domains.
    Khazanov N; Levy Y
    J Mol Biol; 2011 Apr; 408(2):335-55. PubMed ID: 21338609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of mutant p53: Constraints on mechanism highlighted by principal component analysis of the DNA binding domain.
    Ouaray Z; ElSawy KM; Lane DP; Essex JW; Verma C
    Proteins; 2016 Oct; 84(10):1443-61. PubMed ID: 27317883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.
    Krois AS; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11302-E11310. PubMed ID: 30420502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the human p53 core domain in the absence of DNA.
    Wang Y; Rosengarth A; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.
    Emamzadah S; Tropia L; Vincenti I; Falquet B; Halazonetis TD
    J Mol Biol; 2014 Feb; 426(4):936-44. PubMed ID: 24374182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a multidomain human p53 tetramer bound to the natural CDKN1A (p21) p53-response element.
    Emamzadah S; Tropia L; Halazonetis TD
    Mol Cancer Res; 2011 Nov; 9(11):1493-9. PubMed ID: 21933903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity.
    Petty TJ; Emamzadah S; Costantino L; Petkova I; Stavridi ES; Saven JG; Vauthey E; Halazonetis TD
    EMBO J; 2011 Jun; 30(11):2167-76. PubMed ID: 21522129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting.
    Nagaich AK; Zhurkin VB; Durell SR; Jernigan RL; Appella E; Harrington RE
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1875-80. PubMed ID: 10051562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent and active p53 are identical in conformation.
    Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
    Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics of the full-length p53 monomer.
    Chillemi G; Davidovich P; D'Abramo M; Mametnabiev T; Garabadzhiu AV; Desideri A; Melino G
    Cell Cycle; 2013 Sep; 12(18):3098-108. PubMed ID: 23974096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Cho Y; Gorina S; Jeffrey PD; Pavletich NP
    Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of DNA binding of p53 by its C-terminal domain.
    Weinberg RL; Freund SM; Veprintsev DB; Bycroft M; Fersht AR
    J Mol Biol; 2004 Sep; 342(3):801-11. PubMed ID: 15342238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
    Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.